Literature DB >> 26561599

Opposing aging-related shift of excitatory dopamine D1 and inhibitory D3 receptor protein expression in striatum and spinal cord.

Benjamin E Keeler1, Perrine Lallemand1, Mukund M Patel1, Lisandra E de Castro Brás1, Stefan Clemens2.   

Abstract

Normal aging is associated with a decrease in motor function, a concomitant increase in muscle stiffness and tone, and a decrease in dopamine (DA) levels in the spinal cord. The striatum plays a critical role in the control of motor function, and it receives strong DA innervation from the substantia nigra. However, locomotor activity also requires the activation of motoneurons in the lumbar spinal cord, which in the mouse express all five DA receptor subtypes (D1-D5). Of these, the D3 receptor (D3R) expresses the highest affinity to DA and mediates inhibitory actions, while activation of the lower-affinity D1 receptor (D1R) system promotes excitatory effects. To test whether the aging-related decrease in DA levels is associated with corresponding changes in DA receptor protein expression levels, we probed with Western blot and immunohistochemical techniques for D1R and D3R protein expression levels over the normal life span of the mouse. We found that with age D1R expression levels increased in both striatum and spinal cord, while D3R expression levels remained stable in the striatum or slightly decreased in the spinal cord. The resulting D1-to-D3 ratio indicates a strong upregulation of D1R-mediated pathways in old animals, which is particularly pronounced in the lumbar spinal cord. These data suggest that aging may be associated with a shift in DA-mediated pathways in striatum and spinal cord, which in turn could be an underlying factor in the emergence of aging- and DA-related motor dysfunctions such as Parkinson's disease or Restless Legs Syndrome (RLS).
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  dopamine receptor expression; normal aging; spinal cord; striatum

Mesh:

Substances:

Year:  2015        PMID: 26561599      PMCID: PMC4760507          DOI: 10.1152/jn.00390.2015

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  45 in total

1.  Identification and characterization of novel properties of the human D3 dopamine receptor.

Authors:  Eldo V Kuzhikandathil; Ligia Westrich; Samer Bakhos; Jennifer Pasuit
Journal:  Mol Cell Neurosci       Date:  2004-05       Impact factor: 4.314

Review 2.  Histological changes of the dopaminergic nigrostriatal system in aging.

Authors:  A K Stark; B Pakkenberg
Journal:  Cell Tissue Res       Date:  2004-09-08       Impact factor: 5.249

3.  Loss of D2 receptors during aging is partially due to decreased levels of mRNA.

Authors:  E R Mesco; J A Joseph; M J Blake; G S Roth
Journal:  Brain Res       Date:  1991-04-05       Impact factor: 3.252

Review 4.  D3 dopamine receptor, behavioral sensitization, and psychosis.

Authors:  N M Richtand; S C Woods; S P Berger; S M Strakowski
Journal:  Neurosci Biobehav Rev       Date:  2001-07       Impact factor: 8.989

Review 5.  A novel dopamine agonist for the transdermal treatment of Parkinson's disease.

Authors:  Peter Jenner
Journal:  Neurology       Date:  2005-07-26       Impact factor: 9.910

6.  Dopamine D2, D3, and D4 receptor mRNA levels in rat brain and pituitary during aging.

Authors:  A Valerio; M Belloni; M L Gorno; C Tinti; M Memo; P Spano
Journal:  Neurobiol Aging       Date:  1994 Nov-Dec       Impact factor: 4.673

7.  Marked disparity between age-related changes in dopamine and other presynaptic dopaminergic markers in human striatum.

Authors:  John W Haycock; Laurence Becker; Lee Ang; Yoshiaki Furukawa; Oleh Hornykiewicz; Stephen J Kish
Journal:  J Neurochem       Date:  2003-11       Impact factor: 5.372

8.  Dopaminergic modulation of spinal neuronal excitability.

Authors:  Pengcheng Han; Stan T Nakanishi; Michelle A Tran; Patrick J Whelan
Journal:  J Neurosci       Date:  2007-11-28       Impact factor: 6.167

9.  Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses.

Authors:  M Xu; R Moratalla; L H Gold; N Hiroi; G F Koob; A M Graybiel; S Tonegawa
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

10.  Effect of aging on concentrations of D2-receptor-containing neurons in the rat striatum.

Authors:  Z Han; B L Kuyatt; K A Kochman; E B DeSouza; G S Roth
Journal:  Brain Res       Date:  1989-10-02       Impact factor: 3.252

View more
  8 in total

Review 1.  Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?

Authors:  Pengfei Yang; Joel S Perlmutter; Tammie L S Benzinger; John C Morris; Jinbin Xu
Journal:  Ageing Res Rev       Date:  2019-11-22       Impact factor: 10.895

2.  Adenosine A1-Dopamine D1 Receptor Heteromers Control the Excitability of the Spinal Motoneuron.

Authors:  Marla Rivera-Oliver; Estefanía Moreno; Yocasta Álvarez-Bagnarol; Christian Ayala-Santiago; Nicole Cruz-Reyes; Gian Carlo Molina-Castro; Stefan Clemens; Enric I Canela; Sergi Ferré; Vicent Casadó; Manuel Díaz-Ríos
Journal:  Mol Neurobiol       Date:  2018-05-24       Impact factor: 5.590

Review 3.  Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation.

Authors:  Christopher J Earley; George R Uhl; Stefan Clemens; Sergi Ferré
Journal:  Sleep Med       Date:  2016-06-27       Impact factor: 3.492

4.  Morphine responsiveness to thermal pain stimuli is aging-associated and mediated by dopamine D1 and D3 receptor interactions.

Authors:  Sophia Samir; Alexander P Yllanes; Perrine Lallemand; Kori L Brewer; Stefan Clemens
Journal:  Neuroscience       Date:  2017-02-28       Impact factor: 3.590

5.  Mechanisms underlying the endogenous dopaminergic inhibition of spinal locomotor circuit function in Xenopus tadpoles.

Authors:  Laurence D Picton; Keith T Sillar
Journal:  Sci Rep       Date:  2016-10-20       Impact factor: 4.379

6.  Modulation of Rhythmic Activity in Mammalian Spinal Networks Is Dependent on Excitability State.

Authors:  Simon A Sharples; Patrick J Whelan
Journal:  eNeuro       Date:  2017-01-27

7.  Differential Dopamine D1 and D3 Receptor Modulation and Expression in the Spinal Cord of Two Mouse Models of Restless Legs Syndrome.

Authors:  Samantha Meneely; Mai-Lynne Dinkins; Miki Kassai; Shangru Lyu; Yuning Liu; Chien-Te Lin; Kori Brewer; Yuqing Li; Stefan Clemens
Journal:  Front Behav Neurosci       Date:  2018-09-04       Impact factor: 3.558

8.  Localisation of clozapine during experimental autoimmune encephalomyelitis and its impact on dopamine and its receptors.

Authors:  Katharina Robichon; Sven Sondhauss; T William Jordan; Robert A Keyzers; Bronwen Connor; Anne C La Flamme
Journal:  Sci Rep       Date:  2021-02-03       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.